NEW YORK (GenomeWeb) – Next-generation sequencing may be the go-to technology for oncologists, but a new study has demonstrated that using sequencing in combination with other molecular profiling methods might produce better outcomes for patients.
Investigators from OncoDNA, a Gosselies, Belgium-based cancer theranostics company, recently described the use of sequencing, immunohistochemistry, DNA methylation, microsatellite instability testing, and other methods to improve treatment decisions.